Low-cost optical scanner and 3-dimensional printing technology to create lead shielding for radiation therapy of facial skin cancer: First clinical case series

Ankur Sharma; David Sasaki; Daniel W Rickey; Ahmet Leylek; Chad Harris; Kate Johnson; Jorge E Alpuche Aviles; Boyd McCurdy; Andy Egtberts; Rashmi Koul; Arbind Dubey

doi:10.1016/j.adro.2018.02.003

Low-cost optical scanner and 3-dimensional printing technology to create lead shielding for radiation therapy of facial skin cancer: First clinical case series

Adv Radiat Oncol. 2018 Feb 14;3(3):288-296. doi: 10.1016/j.adro.2018.02.003. eCollection 2018 Jul-Sep.

Authors

Ankur Sharma^{1

2}, David Sasaki^{2

3}, Daniel W Rickey^{2

3

4}, Ahmet Leylek^{1

2}, Chad Harris³, Kate Johnson^{1

2}, Jorge E Alpuche Aviles^{2

3

4}, Boyd McCurdy^{2

3

4}, Andy Egtberts³, Rashmi Koul^{1

2}, Arbind Dubey^{1

2}

Affiliations

¹ Department of Radiation Oncology, CancerCare Manitoba, Winnipeg, Manitoba, Canada.
² Department of Radiology, University of Manitoba, Winnipeg, Manitoba, Canada.
³ Department of Medical Physics, CancerCare Manitoba, Winnipeg, Manitoba, Canada.
⁴ Department of Physics and Astronomy, University of Manitoba, Winnipeg, Manitoba, Canada.

Abstract

Purpose: Three-dimensional printing has been implemented at our institution to create customized treatment accessories, including lead shields used during radiation therapy for facial skin cancer. To effectively use 3-dimensional printing, the topography of the patient must first be acquired. We evaluated a low-cost, structured-light, 3-dimensional, optical scanner to assess the clinical viability of this technology.

Methods and materials: For ease of use, the scanner was mounted to a simple gantry that guided its motion and maintained an optimum distance between the scanner and the object. To characterize the spatial accuracy of the scanner, we used a geometric phantom and an anthropomorphic head phantom. The geometric phantom was machined from plastic and included hemispherical and tetrahedral protrusions that were roughly the dimensions of an average forehead and nose, respectively. Polygon meshes acquired by the optical scanner were compared with meshes generated from high-resolution computed tomography images. Most optical scans contained minor artifacts. Using an algorithm that calculated the distances between the 2 meshes, we found that most of the optical scanner measurements agreed with those from the computed tomography scanner within approximately 1 mm for the geometric phantom and approximately 2 mm for the head phantom. We used this optical scanner along with 3-dimensional printer technology to create custom lead shields for 10 patients receiving orthovoltage treatments of nonmelanoma skin cancers of the face. Patient, tumor, and treatment data were documented.

Results: Lead shields created using this approach were accurate, fitting the contours of each patient's face. This process added to patient convenience and addressed potential claustrophobia and medical inability to lie supine.

Conclusions: The scanner was found to be clinically acceptable, and we suggest that the use of an optical scanner and 3-dimensional printer technology become the new standard of care to generate lead shielding for orthovoltage radiation therapy of nonmelanoma facial skin cancer.